OBJECTIVES Observational estimates of bystander automated external defibrillator (AED) effectiveness are inconsistent in settings with mature public-access defibrillation infrastructure but low utilisation, partly because the conventional reference group pools emergency medical services (EMS)-shocked with non-defibrillated patients. We estimated bystander AED effectiveness against a partitioned no-defibrillation reference, tested effect modification by location, and quantified the deployment–utilisation gap.METHODS Retrospective analysis of a prospectively collected multicentre out-of-hospital cardiac arrest (OHCA) registry (Korea, October 2015–June 2025; 23,918 adults of presumed medical aetiology). A three-tier prehospital defibrillation-provider variable was defined: bystander AED applied (n = 383); EMS-delivered shock without preceding bystander AED (n = 5,975); and no prehospital defibrillation (reference; n = 17,560). Primary outcomes were survival to discharge and good neurological outcome (Cerebral Performance Category 1–2), analysed by multivariable logistic regression with propensity-score, inverse-probability-weighting and location-stratified secondary analyses.RESULTS Bystander AED application was associated with improved survival (adjusted odds ratio [aOR] 1.60; 95% CI 1.19–2.14) and good neurological outcome (2.31; 1.65–3.23), comparable to that of EMS-delivered shock; the pooled-control specification attenuated estimates to non-significance (survival 1.09; neurological 1.14). Shock-delivered applications significantly exceeded EMS-delivered shock for neurological outcome (aOR 1.43; P = 0.03). Effectiveness did not differ by location (interaction P ≥ 0.15). Bystander AED was applied in 8.5% of Public-area versus 1.9% of Non-public AED-opportunity cases — a 4.5-fold gap.CONCLUSIONS Bystander AED was associated with improved outcomes when applied, comparable to or exceeding EMS-delivered shock; the dominant constraint was the deployment–utilisation gap, greatest in residential settings. Residential rapid-activation infrastructure warrants policy priority alongside, not instead of, continued device placement.
No takes yet. Share an insight, caveat, or question.
Sohn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: